TransMedics Group, Inc.
TMDX
$87.72
-$0.52-0.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 441.54M | 401.09M | 358.76M | 296.92M | 241.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 441.54M | 401.09M | 358.76M | 296.92M | 241.62M |
| Cost of Revenue | 179.46M | 163.10M | 140.95M | 111.63M | 87.53M |
| Gross Profit | 262.08M | 237.99M | 217.81M | 185.29M | 154.09M |
| SG&A Expenses | 168.62M | 154.27M | 142.27M | 128.73M | 117.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 404.04M | 367.64M | 330.35M | 281.92M | 241.14M |
| Operating Income | 37.50M | 33.46M | 28.41M | 15.00M | 485.00K |
| Income Before Tax | 35.78M | 32.65M | 1.48M | -11.65M | -26.67M |
| Income Tax Expenses | 316.00K | 16.00K | -1.52M | -1.46M | -1.64M |
| Earnings from Continuing Operations | 35.46 | 32.64 | 3.00 | -10.20 | -25.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.46M | 32.64M | 3.00M | -10.20M | -25.03M |
| EBIT | 37.50M | 33.46M | 28.41M | 15.00M | 485.00K |
| EBITDA | 57.25M | 51.14M | 42.81M | 26.19M | 8.66M |
| EPS Basic | 1.07 | 0.99 | 0.08 | -0.31 | -0.77 |
| Normalized Basic EPS | 0.68 | 0.66 | 0.58 | 0.34 | 0.05 |
| EPS Diluted | 1.02 | 0.93 | 0.03 | -0.35 | -0.78 |
| Normalized Diluted EPS | 0.64 | 0.62 | 0.55 | 0.32 | 0.04 |
| Average Basic Shares Outstanding | 132.91M | 131.97M | 131.14M | 130.56M | 130.06M |
| Average Diluted Shares Outstanding | 140.86M | 139.83M | 136.76M | 134.02M | 131.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |